集団検診の市場規模、シェア＆動向分析レポート：地域別（国、州）、製品別（ハードウェア機器）、事業別（病院）、性別、タイプ別、年齢別、地域別、セグメント予測、2023年～2030年

集団検診の市場成長と動向

Grand View Research, Inc.の最新レポートによると、世界の集団検診市場規模は2030年までに382億米ドルに達すると予測されています。同市場は2023年から2030年にかけてCAGR5.36%で拡大すると予測されています。市場の成長は、疾患の有病率の増加、老年人口の増加、集団検診検査への投資の増加などに起因しています。さらに、これらの検査における技術的な進歩や開発の増加により、市場は大きく牽引されると予想されます。

心血管疾患の有病率の上昇は、セグメントの成長を後押しすると予想されます。WHOによると、心血管疾患が原因で毎年1,770万人が死亡しており、これは世界で発生する総死亡者数の31.0%に相当します。また、高血圧とその病的な悪影響は、心不全や脳卒中など、他の心疾患の大きなリスクとなります。死亡率を下げることを目的として、世界的に材料細動のスクリーニングプログラムが複数用意されています。早期の高血圧やその他のCVDを特定することは、これらの疾病に関連する主要な死亡率や罹患率を予測・予防する上で大きな意義があります。

脊髄性筋萎縮症（SMA）などの希少遺伝性疾患の有病率の増加や、人口検診への支出の増加は、市場支配の主な要因の1つとなっています。全米希少疾患機関（NORD）によると、SMAは世界的にほぼ10,000人に1人の割合で発症するとされています。また、SMAカナダによると、2022年7月現在、カナダでは約700人がこの疾患を患っているとされています。例えば、CDCは、SMAの子どもを早期に発見するために、推奨統一スクリーニングパネル（RUSP）を州全体のユニバーサル新生児プログラムの下で各州に公開しました。このように、このようなイニシアチブは、人口のスクリーニングのために政府によって実施され、それによって集団検診市場の成長をサポートしています。

市場のプレーヤーは、製品ポートフォリオを強化し、多様で技術的に高度かつ革新的な集団検診製品を患者に提供するために、製品上市の戦略を採用しています。いくつかの市場参加者は、市場での地位を強化するためにM&Aを実施しています。この戦略により、企業は能力を高め、製品ポートフォリオを拡大し、能力を向上させることができます。例えば、2022年8月、サーモフィッシャーサイエンティフィック社は、抗レトロウイルス治療薬（ART）に抵抗する遺伝子変異を特定するためのHIV-1ジェノタイピングキットを発売しました。このキットは、研究目的にのみ使用されるものでした。

集団検診市場レポートハイライト

2022年の市場セグメンテーションは、CTCが提供するがん検出の有効性と精度により、ナショナルセグメントが圧倒的なシェアを占める

プレミアムセグメントは、民間スクリーニングプログラムの増加により、予測期間中に最も速い速度で成長すると予測されています。

女性による検査数の増加により、2022年には女性セグメントが最も高い収益を上げるセグメントとなる

2022年の集団検診市場は北米が支配的であり、これは疾病の進行を阻止するために政府が実施している予防措置に起因しています。

目次

第1章 調査手法と範囲

• 市場セグメンテーション
• 調査手法
• 情報調達
  • 購入したデータベース
  • 二次情報
  • 1次調査
  • 1次調査の詳細
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析
    • アプローチ1：コモディティフローアプローチ
    • アプローチ2：ボトムアップアプローチを使用した国別の市場推定
• 世界市場：CAGR計算
• 調査の仮定
• 二次情報一覧
• 一次情報のリスト
• 目的
• 略語一覧

第2章 エグゼクティブサマリー

• 市場のスナップショット
• セグメントのスナップショット
• 競合情勢のスナップショット

第3章 集団検診市場の変数、動向、および範囲

• 集団検診市場系統の見通し
  • 親市場の見通し
    • 細胞健康スクリーニング市場の見通し
    • 体外診断市場の見通し
• 浸透と成長の見通しのマッピング
• 市場促進要因分析
  • 病気の有病率の増加
  • 集団検診への投資の増加
  • 高齢者人口の増加
• 市場抑制要因分析
  • スクリーニングに伴う高コスト
  • 心理的要因、知識、態度、信念
• 要因別SWOT分析（政治と法律、経済、技術）
• ポーターのファイブフォース分析
• 規制の枠組み

第4章 集団検診市場-セグメント分析、地域別、2018年から地域年（百万米ドル）

• 定義と範囲
• 集団検診市場：地域変動分析
  • 国
  • 州

第5章 集団検診市場-セグメント分析、製品別、2018年から2030年（百万米ドル）

• 集団検診市場：製品変動分析
  • ハードウェア機器（機器、キット、チップ）
  • テスト/ラボ（サービス）
  • 分析/解釈（パーソナライゼーションと解釈）

第6章 集団検診市場-セグメント分析、ビジネス別、2018年から2030年（百万米ドル）

• 定義と範囲
• 集団検診市場：ビジネス変動分析
  • 病院
  • 調査
  • 診断ラボ

第7章 集団検診市場-セグメント分析、性別、2018年から2030年（100万米ドル）

• 定義と範囲
• 集団検診市場：性別変動分析
  • 男
  • 女性

第8章 集団検診市場-セグメント分析、タイプ別、2018年から2030年（百万米ドル）

• 定義と範囲
• 集団検診市場：タイプ変動分析
  • 質量
  • プレミアム

第9章 集団検診市場-セグメント分析、年齢別、2018年から2030年（百万米ドル）

• 定義と範囲
• 集団検診市場：年齢変動分析
  • 15歳未満
    • 15歳未満の市場推計・予測、2018～2030年（USD Million）
  • 15-65
  • 65歳以上

第10章 地域ビジネス分析

• 定義と範囲
• 地域市場シェア分析、2021年および2030年
• 地域市場ダッシュボード
• 地域市場のスナップショット
• SWOT分析、要因別（政治と法律、経済と技術）
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • MEA
• 市場規模、予測、トレンド分析、2021年から2030年
• 北米
  • 米国
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • カナダ
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
• 欧州
  • 英国
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • ドイツ
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • スペイン
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • フランス
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • イタリア
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • デンマーク
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • スウェーデン
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • ノルウェー
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
• アジア太平洋地域
  • 日本
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • 中国
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • インド
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • 韓国
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • タイ
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • オーストラリア
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
• ラテンアメリカ
  • ブラジル
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • メキシコ
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • アルゼンチン
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
• MEA
  • 南アフリカ
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • サウジアラビア
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • アラブ首長国連邦
    • 主要な国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • クウェート
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ

第11章 競合分析

• 企業/競合の分類（主要なイノベーター、市場のリーダー、新興企業）
• 戦略的枠組み
• 市場参加の分類
• 主要な市場参入企業別最近の動向と影響分析
• 会社のポジション分析
• 代理店一覧
  • 主要顧客
  • 公開会社
  • 非公開会社
• ケーススタディ
  • 検診を行ったCvd患者と検診を行わなかったCvd患者のコスト分析
  • ケーススタディ：集団健康検診
  • ケーススタディ：Agilent Quickprobe GC/Mシステムを使用した生のケースサンプルの検診
  • ケーススタディ：スクリーニングのためのHPVテストを評価するためのRoche Cobas 4800 HPVテストのパフォーマンスの評価
  • ケーススタディ：糖尿病におけるグルコースとヘモグロビンの測定

第12章 企業プロファイル

• 企業プロファイル
  • AGILENT TECHNOLOGIES, INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • THERMO FISHER SCIENTIFIC, INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • QIAGEN
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • F. HOFFMANN-LA ROCHE LTD
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • QUEST DIAGNOSTICS
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • ILLUMINA, INC
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • ARUP LABORATORIES
    • 会社概要
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • NOVOGENE CO., LTD.
    • 会社概要
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • LGC LIMITED
    • 会社概要
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • GENE BY GENE, LTD.
    • 会社概要
    • 製品のベンチマーク

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Regulatory Framework
• Table 4 Global Population Screening Market, By Region, 2018 - 2030 (USD Million)
• Table 5 Global Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 6 Global Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 7 Global Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 8 Global Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 9 Global Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 10 Global Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 11 North America Population Screening Market, By Country, 2018 - 2030, (USD Million)
• Table 12 North America Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 13 North America Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 14 North America Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 15 North America Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 16 North America Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 17 North America Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 18 U.S. Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 19 U.S. Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 20 U.S. Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 21 U.S. Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 22 U.S. Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 23 U.S. Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 24 Canada Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 25 Canada Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 26 Canada Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 27 Canada Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 28 Canada Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 29 Canada Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 30 Europe Population Screening Market, By Country, 2018 - 2030, (USD Million)
• Table 31 Europe Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 32 Europe Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 33 Europe Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 34 Europe Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 35 Europe Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 36 Europe Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 37 UK Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 38 UK Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 39 UK Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 40 UK Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 41 UK Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 42 UK Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 43 Germany Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 44 Germany Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 45 Germany Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 46 Germany Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 47 Germany Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 48 Germany Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 49 France Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 50 France Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 51 France Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 52 France Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 53 France Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 54 France Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 55 Spain Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 56 Spain Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 57 Spain Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 58 Spain Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 59 Spain Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 60 Spain Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 61 Italy Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 62 Italy Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 63 Italy Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 64 Italy Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 65 Italy Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 66 Italy Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 67 Denmark Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 68 Denmark Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 69 Denmark Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 70 Denmark Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 71 Denmark Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 72 Denmark Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 73 Sweden Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 74 Sweden Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 75 Sweden Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 76 Sweden Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 77 Sweden Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 78 Sweden Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 79 Norway Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 80 Norway Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 81 Norway Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 82 Norway Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 83 Norway Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 84 Norway Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 85 Asia Pacific Population Screening Market, By Country, 2018 - 2030, (USD Million)
• Table 86 Asia Pacific Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 87 Asia Pacific Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 88 Asia Pacific Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 89 Asia Pacific Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 90 Asia Pacific Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 91 Asia Pacific Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 92 Japan Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 93 Japan Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 94 Japan Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 95 Japan Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 96 Japan Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 97 Japan Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 98 China Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 99 China Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 100 China Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 101 China Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 102 China Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 103 China Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 104 Australia Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 105 Australia Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 106 Australia Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 107 Australia Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 108 Australia Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 109 Australia Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 110 Thailand Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 111 Thailand Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 112 Thailand Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 113 Thailand Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 114 Thailand Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 115 Thailand Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 116 India Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 117 India Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 118 India Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 119 India Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 120 India Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 121 India Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 122 South Korea Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 123 South Korea Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 124 South Korea Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 125 South Korea Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 126 South Korea Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 127 South Korea Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 128 Latin America Population Screening Market, By Country, 2018 - 2030, (USD Million)
• Table 129 Latin America Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 130 Latin America Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 131 Latin America Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 132 Latin America Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 133 Latin America Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 134 Latin America Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 135 Mexico Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 136 Mexico Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 137 Mexico Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 138 Mexico Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 139 Mexico Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 140 Mexico Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 141 Brazil Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 142 Brazil Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 143 Brazil Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 144 Brazil Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 145 Brazil Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 146 Brazil Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 147 Argentina Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 148 Argentina Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 149 Argentina Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 150 Argentina Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 151 Argentina Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 152 Argentina Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 153 MEA Population Screening Market, By Country, 2018 - 2030, (USD Million)
• Table 154 MEA Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 155 MEA Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 156 MEA Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 157 MEA Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 158 MEA Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 159 MEA Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 160 South Africa Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 161 South Africa Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 162 South Africa Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 163 South Africa Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 164 South Africa Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 165 South Africa Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 166 South Africa Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 167 Saudi Arabia Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 168 Saudi Arabia Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 169 Saudi Arabia Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 170 Saudi Arabia Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 171 Saudi Arabia Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 172 Saudi Arabia Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 173 Saudi Arabia Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 174 UAE Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 175 UAE Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 176 UAE Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 177 UAE Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 178 UAE Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 179 UAE Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 180 Kuwait Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 181 Kuwait Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 182 Kuwait Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 183 Kuwait Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 184 Kuwait Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 185 Kuwait Population Screening Market, By Age, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Population screening market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Commodity flow approach
• Fig. 10 Market snapshot (2022) (USD Million)
• Fig. 11 Segment Snapshot (2022) (USD Million)
• Fig. 12 Segment Snapshot (2022) (USD Million)
• Fig. 13 Segment Snapshot (2022) (USD Million)

Fig. 14 Market Outlook (2022) (USD Million)

• Fig. 15 Penetration & growth prospect mapping
• Fig. 16 Population screening market driver impact
• Fig. 17 Global cancer cases projection, 2020-2030 (Number of newly registered cases)
• Fig. 18 Distinguishing screening from early diagnosis of cancer according to symptom onset
• Fig. 19 Elderly population total, % of the global population
• Fig. 20 Population screening market restraint impact
• Fig. 21 PESTEL analysis
• Fig. 22 Porter's Five Forces analysis
• Fig. 23 Population screening geography outlook: Key takeaways
• Fig. 24 Population screening market: Geography movement analysis
• Fig. 25 Nation market 2018 - 2030 (USD Million)
• Fig. 26 State market, 2018 - 2030 (USD Million)
• Fig. 27 Population screening product analysis outlook: Key takeaways
• Fig. 28 Population screening market: Product movement analysis
• Fig. 29 Hardware and Equipment market, 2018 - 2030 (USD Million)
• Fig. 30 Testing/lab (services) market, 2018 - 2030 (USD Million)
• Fig. 31 Analytics/interpretation market, 2018 - 2030 (USD Million)
• Fig. 32 Population screening business outlook: Key takeaways
• Fig. 33 Population screening market: business analysis
• Fig. 34 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 35 Research institute market, 2018 - 2030 (USD Million)
• Fig. 36 Diagnostic labs market, 2018 - 2030 (USD Million)
• Fig. 37 Population screening gender outlook: Key takeaways
• Fig. 38 Population screening market: Gender analysis
• Fig. 39 Male market, 2018 - 2030 (USD Million)
• Fig. 40 Current screening statistics CDC (2022)
• Fig. 41 Female market, 2018 - 2030 (USD Million)
• Fig. 42 Population screening type outlook: Key takeaways
• Fig. 43 Population screening market: Type analysis
• Fig. 44 Mass market, 2018 - 2030 (USD Million)
• Fig. 45 Premium market, 2018 - 2030 (USD Million)
• Fig. 46 Population screening age outlook: Key takeaways
• Fig. 47 Population screening market: Age analysis
• Fig. 48 Ages 15 market, 2018 - 2030 (USD Million)
• Fig. 49 15-65 years market, 2018 - 2030 (USD Million)
• Fig. 50 Ages 65+ years market, 2018 - 2030 (USD Million)
• Fig. 51 Regional snapshot, 2021 & 2030
• Fig. 52 Regional marketplace: Key takeaways
• Fig. 53 Crude & effective coverage for cervical cancer screening across women aged 25 - 64
• Fig. 54 Global population screening market, 2018 - 2030 (USD Million)
• Fig. 55 North America population screening market, 2018 - 2030 (USD Million)
• Fig. 56 Europe population screening market, 2018 - 2030 (USD Million)
• Fig. 57 Asia Pacific population screening market, 2018 - 2030 (USD Million)
• Fig. 58 Latin America population screening market, 2018 - 2030 (USD Million)
• Fig. 59 Middle East and Africa population screening market, 2018 - 2030 (USD Million)
• Fig. 60 GCC population screening market, 2018 - 2030 (USD Million)
• Fig. 61 Rest of GCC population screening market, 2018 - 2030 (USD Million)
• Fig. 62 UAE population screening market, 2018 - 2030 (USD Million)
• Fig. 63 Australia population screening market, 2018 - 2030 (USD Million)
• Fig. 64 Percentage of screening for chronic diseases in 2017 and 2020
• Fig. 65 Singapore population screening market, 2018 - 2030 (USD Million)
• Fig. 66 UK population screening market, 2018 - 2030 (USD Million)
• Fig. 67 Thailand population screening market, 2018 - 2030 (USD Million)
• Fig. 68 ASEAN countries population screening market, 2018 - 2030 (USD Million)
• Fig. 69 Recent company/competition categorization

Population Screening Market Growth & Trends:

The global population screening market size is expected to reach USD 38.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.36% from 2023 to 2030. The growth of the market is attributed to the increasing prevalence of diseases, the growing geriatric population, and increasing investment in population screening tests. Moreover, the market is expected to be driven significantly by increasing technological advancements and developments in these tests.

An increase in the prevalence of cardiovascular diseases is expected to boost segment growth. According to the WHO, 17.7 million people die annually due to cardiovascular diseases, which is 31.0% of the total deaths occurring worldwide. Cardiovascular diseases are the leading cause of mortality and morbidity in the U.S. They are among the main causes of death globally, and hypertension & its pathological adverse effects pose a significant risk for other cardiac diseases, such as heart failure & stroke. There are multiple screening programs available for material fibrillation globally that aim to reduce the mortality rate. Identifying early-stage hypertension and other CVDs is of high significance in predicting & preventing major mortality & morbidity related to these diseases.

The growing prevalence of rare genetic diseases such as Spinal Muscular Atrophy (SMA) disorders and increased spending on population screening are among the major factors for the dominance of the market. According to the National Organization for Rare Disorders (NORD), SMA affects almost one in 10,000 people globally. In addition, according to SMA Canada, approximately 700 people were living with this condition in Canada as of July 2022. For instance, the CDC released the Recommended Uniform Screening Panel (RUSP) to states under its statewide universal newborn programs for the early identification of children with SMA. Thus, such initiatives are undertaken by governments to screen the population, thereby supporting the growth of the population screening market.

Players in the market adopt the strategy of product launches to strengthen their product portfolio and offer diverse, technologically advanced, & innovative population screening products to patients. Several market players engage in mergers & acquisitions to strengthen their market position. This strategy enables companies to boost their capabilities, expand product portfolios, and improve competencies. For instance, in August 2022, Thermo Fisher Scientific, Inc., launched an HIV-1 genotyping kit to identify the genetic mutations that resist Antiretroviral Therapeutics (ART). This kit was intended only for research purposes.

Population Screening Market Report Highlights:

• The nation segment held a dominant share of the market in 2022 owing to the effectiveness and precision offered by CTCs in the detection of cancer

• The premium segment is projected to grow at the fastest rate over the forecast period owing to the increasing dominance of private screening programs

• The female segment is the highest revenue-generating segment in 2022 owing to the increasing number of tests being performed by females

• North America dominated the population screening market in 2022, which is attributed to preventive measures undertaken by governments to stop the progression of diseases

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation
  • 1.1.1 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 Secondary Sources
  • 1.3.3 Primary Research
  • 1.3.4 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
• 1.7 Global Market: CAGR Calculation
• 1.8 Research Assumptions
• 1.9 List of Secondary Sources
• 1.10 List of Primary Sources
• 1.11 Objectives
  • 1.11.1 Objective 1
  • 1.11.2 Objective 2
• 1.12 List of Abbreviations

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Competitive Landscape Snapshot

Chapter 3 Popular Screening Market Variables, Trends & Scope

• 3.1 Population Screening Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
    • 3.1.1.1 Cellular Health Screening Market Outlook
    • 3.1.1.2 In Vitro Diagnostics Market Outlook
• 3.2 Penetration and Growth Prospect Mapping
• 3.3 Market Driver Analysis
  • 3.3.1 Increasing Prevalence Of Diseases
  • 3.3.2 Growing Investments In Population Screening
  • 3.3.3 Growing Geriatric Population
• 3.4 Market Restraint Analysis
  • 3.4.1 High Cost Associated With Screening
  • 3.4.2 Psychological Factors, Knowledge, Attitudes, And Beliefs
• 3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
• 3.6 Porter's Five Forces Analysis
• 3.7 Regulatory Framework

Chapter 4 Population Screening Market - Segment Analysis, by Geography, 2018 - 2030 (USD Million)

• 4.1 Definition and Scope
• 4.2 Population Screening Market: Geography Movement Analysis
  • 4.2.1 Nation
    • 4.2.1.1 Nation Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.2.2 State
    • 4.2.2.1 State market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Population Screening Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

• 5.1 Population Screening Market: Product Movement Analysis
  • 5.1.1 Hardware Equipment (Instrument, Kits, Chips)
    • 5.1.1.1 Hardware Equipment (Instrument, Kits, Chips) Market Estimates And Forecast, 2018 - 2030 (Usd Million)
  • 5.1.2 Testing/Lab (Services)
    • 5.1.2.1 Testing/Lab (Services) Market Estimates And Forecast, 2018 - 2030 (Usd Million)
  • 5.1.3 Analytics/Interpretation (Personalization And Interpretation)
    • 5.1.3.1 Analytics/Interpretation (Personalisation and interpretation) market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Population Screening Market - Segment Analysis, by Business, 2018 - 2030 (USD Million)

• 6.1 Definition and Scope
• 6.2 Population Screening Market: Business Movement Analysis
  • 6.2.1 Hospitals
    • 6.2.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (Usd Million)
  • 6.2.2 Research Institutes
    • 6.2.2.1 Research Institutes Market Estimates And Forecast, 2018 - 2030 (Usd Million)
  • 6.2.3 Diagnostic Labs
    • 6.2.3.1 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Population Screening Market - Segment Analysis, by Gender, 2018 - 2030 (USD Million)

• 7.1 Definition and Scope
• 7.2 Population Screening Market: Gender Movement Analysis
  • 7.2.1 Male
    • 7.2.1.1 Male Market Estimates And Forecast, 2018 - 2030 (Usd Million)
  • 7.2.2 Female
    • 7.2.2.1 Female market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Population Screening Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

• 8.1 Definition and Scope
• 8.2 Population Screening Market: Type Movement Analysis
  • 8.2.1 Mass
    • 8.2.1.1 Mass Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.2.2 Premium
    • 8.2.2.1 Premium market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Population Screening Market - Segment Analysis, by Age, 2018 - 2030 (USD Million)

• 9.1 Definition and Scope
• 9.2 Population Screening Market: Age Movement Analysis
  • 9.2.1 Age <15
    • 9.2.1.1 Age <15 Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 9.2.2 15-65
    • 9.2.2.1 15-65 Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 9.2.3 Ages 65+
    • 9.2.3.1 Ages 65+ market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10 Regional Business Analysis

• 10.1 Definition & Scope
• 10.2 Regional Market Share Analysis, 2021 & 2030
• 10.3 Regional Market Dashboard
• 10.4 Regional Market Snapshot
• 10.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • 10.5.1 North America
  • 10.5.2 Europe
  • 10.5.3 Asia Pacific
  • 10.5.4 Latin America
  • 10.5.5 MEA
• 10.6 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
• 10.7 North America
  • 10.7.1 North America Market Estimates And Forecast, 2018 - 2030 (USD MILLION)
  • 10.7.2 U.S.
    • 10.7.2.1 U.S. Population Screening Market, 2018 - 2030 (USD Million)
    • 10.7.2.2 Key country Dynamics
    • 10.7.2.3 Regulatory Framework
    • 10.7.2.4 Competitive Scenario
    • 10.7.2.5 Recent Developments
    • 10.7.2.6 Investments Scenario
  • 10.7.3 Canada
    • 10.7.3.1 Canada Population Screening Market, 2018 - 2030 (USD Million)
    • 10.7.3.2 Key country Dynamics
    • 10.7.3.3 Regulatory Framework
    • 10.7.3.4 Competitive Scenario
    • 10.7.3.5 Recent Developments
    • 10.7.3.6 Investments Scenario
• 10.8 Europe
  • 10.8.1 Europe Population Screening Market, 2018 - 2030 (USD Million)
  • 10.8.2 UK
    • 10.8.2.1 UK Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.2.2 Key country Dynamics
    • 10.8.2.3 Regulatory Framework
    • 10.8.2.4 Competitive Scenario
    • 10.8.2.5 Recent Developments
    • 10.8.2.6 Investments Scenario
  • 10.8.3 Germany
    • 10.8.3.1 Germany Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.3.2 Key country Dynamics
    • 10.8.3.3 Regulatory Framework
    • 10.8.3.4 Competitive Scenario
    • 10.8.3.5 Recent Developments
    • 10.8.3.6 Investments Scenario
  • 10.8.4 Spain
    • 10.8.4.1 Spain Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.4.2 Key country Dynamics
    • 10.8.4.3 Regulatory Framework
    • 10.8.4.4 Competitive Scenario
    • 10.8.4.5 Recent Developments
    • 10.8.4.6 Investments Scenario
  • 10.8.5 France
    • 10.8.5.1 France Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.5.2 Key country Dynamics
    • 10.8.5.3 Regulatory Framework
    • 10.8.5.4 Competitive Scenario
    • 10.8.5.5 Recent Developments
    • 10.8.5.6 Investments Scenario
  • 10.8.6 Italy
    • 10.8.6.1 Italy Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.6.2 Key country Dynamics
    • 10.8.6.3 Regulatory Framework
    • 10.8.6.4 Competitive Scenario
    • 10.8.6.5 Recent Developments
    • 10.8.6.6 Investments Scenario
  • 10.8.7 Denmark
    • 10.8.7.1 Denmark Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.7.2 Key country Dynamics
    • 10.8.7.3 Regulatory Framework
    • 10.8.7.4 Competitive Scenario
    • 10.8.7.5 Recent Developments
    • 10.8.7.6 Investments Scenario
  • 10.8.8 Sweden
    • 10.8.8.1 Sweden Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.8.2 Key country Dynamics
    • 10.8.8.3 Regulatory Framework
    • 10.8.8.4 Competitive Scenario
    • 10.8.8.5 Recent Developments
    • 10.8.8.6 Investments Scenario
  • 10.8.9 Norway
    • 10.8.9.1 Norway Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.9.2 Key country Dynamics
    • 10.8.9.3 Regulatory Framework
    • 10.8.9.4 Competitive Scenario
    • 10.8.9.5 Recent Developments
    • 10.8.9.6 Investments Scenario
• 10.9 Asia Pacific
  • 10.9.1 Asia-Pacific Population Screening Market, 2018 - 2030 (USD Million)
  • 10.9.2 Japan
    • 10.9.2.1 Japan Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.9.2.2 Key Country Dynamics
    • 10.9.2.3 Regulatory Framework
    • 10.9.2.4 Competitive Scenario
    • 10.9.2.5 Recent Developments
    • 10.9.2.6 Investments Scenario
  • 10.9.3 China
    • 10.9.3.1 China Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.9.3.2 Key Country Dynamics
    • 10.9.3.3 Regulatory Framework
    • 10.9.3.4 Competitive Scenario
    • 10.9.3.5 Recent Developments
    • 10.9.3.6 Investments Scenario
  • 10.9.4 India
    • 10.9.4.1 India Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.9.4.2 Key Country Dynamics
    • 10.9.4.3 Regulatory Framework
    • 10.9.4.4 Competitive Scenario
    • 10.9.4.5 Recent Developments
    • 10.9.4.6 Investments Scenario
  • 10.9.5 South Korea
    • 10.9.5.1 South Korea Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.9.5.2 Key Country Dynamics
    • 10.9.5.3 Regulatory Framework
    • 10.9.5.4 Competitive Scenario
    • 10.9.5.5 Recent Developments
    • 10.9.5.6 Investments Scenario
  • 10.9.6 Thailand
    • 10.9.6.1 Thailand Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.9.6.2 Key Country Dynamics
    • 10.9.6.3 Regulatory Framework
    • 10.9.6.4 Competitive Scenario
    • 10.9.6.5 Recent Developments
    • 10.9.6.6 Investments Scenario
  • 10.9.7 Australia
    • 10.9.7.1 Australia Population Screening Market, 2018 - 2030 (USD Million)
    • 10.9.7.2 Key country Dynamics
    • 10.9.7.3 Regulatory Framework
    • 10.9.7.4 Competitive Scenario
    • 10.9.7.5 Recent Developments
    • 10.9.7.6 Investments Scenario
• 10.10 Latin America
  • 10.10.1 Latin America Population Screening Market, 2018 - 2030 (USD Million)
  • 10.10.2 Brazil
    • 10.10.2.1 Brazil Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.10.2.2 Key Country Dynamics
    • 10.10.2.3 Regulatory Framework
    • 10.10.2.4 Competitive Scenario
    • 10.10.2.5 Recent Developments
    • 10.10.2.6 Investments Scenario
  • 10.10.3 Mexico
    • 10.10.3.1 Mexico Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.10.3.2 Key Country Dynamics
    • 10.10.3.3 Regulatory Framework
    • 10.10.3.4 Competitive Scenario
    • 10.10.3.5 Recent Developments
    • 10.10.3.6 Investments Scenario
  • 10.10.4 Argentina
    • 10.10.4.1 Argentina Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.10.4.2 Key Country Dynamics
    • 10.10.4.3 Regulatory Framework
    • 10.10.4.4 Competitive Scenario
    • 10.10.4.5 Recent Developments
    • 10.10.4.6 Investments Scenario
• 10.11 MEA
  • 10.11.1 Mea Population Screening Market, 2018 - 2030 (Usd Million)
  • 10.11.2 South Africa
    • 10.11.2.1 South Africa Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.11.2.2 Key Country Dynamics
    • 10.11.2.3 Regulatory Framework
    • 10.11.2.4 Competitive Scenario
    • 10.11.2.5 Recent Developments
    • 10.11.2.6 Investments Scenario
  • 10.11.3 Saudi Arabia
    • 10.11.3.1 Saudi Arabia Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.11.3.2 Key Country Dynamics
    • 10.11.3.3 Regulatory Framework
    • 10.11.3.4 Competitive Scenario
    • 10.11.3.5 Recent Developments
    • 10.11.3.6 Investments Scenario
  • 10.11.4 UAE
    • 10.11.4.1 Uae Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.11.4.2 Key Country Dynamics
    • 10.11.4.3 Regulatory Framework
    • 10.11.4.4 Competitive Scenario
    • 10.11.4.5 Recent Developments
    • 10.11.4.6 Investments Scenario
  • 10.11.5 Kuwait
    • 10.11.5.1 Kuwait Population Screening Market, 2018 - 2030 (USD Million)
    • 10.11.5.2 Key country Dynamics
    • 10.11.5.3 Regulatory Framework
    • 10.11.5.4 Competitive Scenario
    • 10.11.5.5 Recent Developments
    • 10.11.5.6 Investments Scenario

Chapter 11 Competitive Analysis

• 11.1 Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
• 11.2 Strategy Framework
• 11.3 Market Participation Categorization
• 11.4 Recent Developments & Impact Analysis, by Key Market Participants
• 11.5 Company Position Analysis
• 11.6 List of Distributors
  • 11.6.1 Key Customers
  • 11.6.2 Public Companies
  • 11.6.3 Private Companies
• 11.7 Case Studies
  • 11.7.1 Cost Analysis Of Cvd Patients With Screening Vs No Screening
  • 11.7.2 Case Study: Population Health Screening
  • 11.7.3 Case Study: Screening Of Raw Cases Samples Using The Agilent Quickprobe Gc/Ms System
  • 11.7.4 Case Study: Evaluate The Performance Of Roche Cobas 4800 Hpv Test For Evaluating Hpv Tests For Screening
  • 11.7.5 Case Study: Measurement Of Glucose And Hemoglobin In Diabetes

Chapter 12 COMPANY PROFILES

• 12.1 Company Profiles
  • 12.1.1 AGILENT TECHNOLOGIES, INC.
    • 12.1.1.1 Company Overview
    • 12.1.1.2 Financial Performance
    • 12.1.1.3 Product Benchmarking
    • 12.1.1.4 Strategic Initiatives
  • 12.1.2 THERMO FISHER SCIENTIFIC, INC.
    • 12.1.2.1 Company Overview
    • 12.1.2.2 Financial performance
    • 12.1.2.3 Product Benchmarking
    • 12.1.2.4 Strategic Initiatives
  • 12.1.3 QIAGEN
    • 12.1.3.1 Company Overview
    • 12.1.3.2 Financial performance
    • 12.1.3.3 Product Benchmarking
    • 12.1.3.4 Strategic Initiatives
  • 12.1.4 F. HOFFMANN-LA ROCHE LTD
    • 12.1.4.1 Company Overview
    • 12.1.4.2 Financial performance
    • 12.1.4.3 Product Benchmarking
    • 12.1.4.4 Strategic Initiatives
  • 12.1.5 QUEST DIAGNOSTICS
    • 12.1.5.1 Company Overview
    • 12.1.5.2 Financial performance
    • 12.1.5.3 Product Benchmarking
    • 12.1.5.4 Strategic Initiatives
  • 12.1.6 ILLUMINA, INC
    • 12.1.6.1 Company Overview
    • 12.1.6.2 Financial performance
    • 12.1.6.3 Product Benchmarking
    • 12.1.6.4 Strategic Initiatives
  • 12.1.7 ARUP LABORATORIES
    • 12.1.7.1 Company Overview
    • 12.1.7.2 Product Benchmarking
    • 12.1.7.3 Strategic Initiatives
  • 12.1.8 NOVOGENE CO., LTD.
    • 12.1.8.1 Company Overview
    • 12.1.8.2 Product Benchmarking
    • 12.1.8.3 Strategic Initiatives
  • 12.1.9 LGC LIMITED
    • 12.1.9.1 Company Overview
    • 12.1.9.2 Product Benchmarking
    • 12.1.9.3 Strategic Initiatives
  • 12.1.10 GENE BY GENE, LTD.
    • 12.1.10.1 Company Overview
    • 12.1.10.2 Product Benchmarking